TrialBMC nephrology2015

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.

Howard Trachtman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.